Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 32
2016 69
2017 86
2018 73
2019 83
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

324 results
Results by year
Filters applied: . Clear all
Page 1
Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana.
Milligan MG, Bigger E, Abramson JS, Sohani AR, Zola M, Kayembe MKA, Medhin H, Suneja G, Lockman S, Chabner BA, Dryden-Peterson SL. Milligan MG, et al. J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00084. J Glob Oncol. 2018. PMID: 30241264 Free PMC article.
Currently, there are few data regarding the sociodemographic factors, clinical characteristics, and outcomes of non-Hodgkin lymphoma (NHL)-an AIDS-defining cancer-in the country. ...Treatment patterns and clinical outcomes were analyzed. RESULTS: One hundred four pa …
Currently, there are few data regarding the sociodemographic factors, clinical characteristics, and outcomes of non-Hodgkin lymphoma (NHL)-a …
Improving HIV Care Engagement in the South from the Patient and Provider Perspective: The Role of Stigma, Social Support, and Shared Decision-Making.
Taylor BS, Fornos L, Tarbutton J, Muñoz J, Saber JA, Bullock D, Villarreal R, Nijhawan AE. Taylor BS, et al. AIDS Patient Care STDS. 2018 Sep;32(9):368-378. doi: 10.1089/apc.2018.0039. AIDS Patient Care STDS. 2018. PMID: 30179530 Free PMC article.
The study was conducted in two large majority/minority HIV treatment centers in the United States (US) south, a geographical region disproportionately impacted by HIV. ...Using Grounded Theory to frame analysis, we found similar perspectives for all groups, including belie …
The study was conducted in two large majority/minority HIV treatment centers in the United States (US) south, a geographical region d …
Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United States.
Chan PA, Patel RR, Mena L, Marshall BD, Rose J, Sutten Coats C, Montgomery MC, Tao J, Sosnowy C, Mayer KH, Nunn A. Chan PA, et al. J Int AIDS Soc. 2019 Aug;22(8):e25385. doi: 10.1002/jia2.25385. J Int AIDS Soc. 2019. PMID: 31423756 Free PMC article.
Self-reported adherence was strongly correlated with retention. In multivariable analyses, younger age was associated with decreased odds of retention at initial follow-up, and completing college was associated with increased odds of retention at 16 months. ...
Self-reported adherence was strongly correlated with retention. In multivariable analyses, younger age was associated with decreased …
Disclosure of HIV serostatus and condomless sex among men living with HIV/AIDS in Florida.
Cook CL, Staras SAS, Zhou Z, Chichetto N, Cook RL. Cook CL, et al. PLoS One. 2018 Dec 17;13(12):e0207838. doi: 10.1371/journal.pone.0207838. eCollection 2018. PLoS One. 2018. PMID: 30557362 Free PMC article.
Despite campaigns to increase safer sex practices, there are people living with HIV/AIDS (PLWH) who do not disclose their HIV status to sexual partners and engage in condomless sex. ...
Despite campaigns to increase safer sex practices, there are people living with HIV/AIDS (PLWH) who do not disclose their HIV status …
Trends in ART Prescription and Viral Suppression Among HIV-Positive Young Adults in Care in the United States, 2009-2013.
Beer L, Mattson CL, Bradley H, Shouse RL; Medical Monitoring Project. Beer L, et al. J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e1-e6. doi: 10.1097/QAI.0000000000001427. J Acquir Immune Defic Syndr. 2017. PMID: 28489729 Free PMC article.
We sought to examine trends in treatment and health outcomes from 2009 to 2013 among HIV-positive young adults (aged 18-24 years) in care. ...There was no significant change in adherence, side effects, or regular care utilization. Although viral suppression at last …
We sought to examine trends in treatment and health outcomes from 2009 to 2013 among HIV-positive young adults (aged 18-24 years) in …
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, Chege W, Postle BS, Matheson T, Amico KR, Liegler T, Rawlings MK, Trainor N, Blue RW, Estrada Y, Coleman ME, Cardenas G, Feaster DJ, Grant R, Philip SS, Elion R, Buchbinder S, Kolber MA. Liu AY, et al. JAMA Intern Med. 2016 Jan;176(1):75-84. doi: 10.1001/jamainternmed.2015.4683. JAMA Intern Med. 2016. PMID: 26571482 Free PMC article.
OBJECTIVE: To assess PrEP adherence, sexual behaviors, and the incidence of STIs and HIV infection in a cohort of MSM and transgender women initiating PrEP in the United States. ...Adherence was higher among those participants who reported more risk behaviors. Inter …
OBJECTIVE: To assess PrEP adherence, sexual behaviors, and the incidence of STIs and HIV infection in a cohort of MSM and transgender …
Syndemic factors associated with adherence to antiretroviral therapy among HIV-positive adult heterosexual men.
McMahon JM, Braksmajer A, Zhang C, Leblanc N, Chen M, Aidala A, Simmons J. McMahon JM, et al. AIDS Res Ther. 2019 Nov 9;16(1):32. doi: 10.1186/s12981-019-0248-9. AIDS Res Ther. 2019. PMID: 31706357 Free PMC article.
BACKGROUND: Suboptimal adherence to HIV antiretroviral therapy (ART) and concomitant lack of viral control can have severe consequences for health and onward transmission among persons living with HIV. Little is known about the barriers and facilitators of optimal ART a
BACKGROUND: Suboptimal adherence to HIV antiretroviral therapy (ART) and concomitant lack of viral control can have severe consequenc …
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ. Landovitz RJ, et al. PLoS Med. 2018 Nov 8;15(11):e1002690. doi: 10.1371/journal.pmed.1002690. eCollection 2018 Nov. PLoS Med. 2018. PMID: 30408115 Free PMC article. Clinical Trial.
BACKGROUND: Cabotegravir (CAB) is a novel strand-transfer integrase inhibitor being developed for HIV treatment and prevention. ...The safety and pharmacokinetic results observed support the further development of CAB LA, and efficacy studies of CAB LA for HIV treatment
BACKGROUND: Cabotegravir (CAB) is a novel strand-transfer integrase inhibitor being developed for HIV treatment and prevention. ...Th …
Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.
Wood S, Gross R, Shea JA, Bauermeister JA, Franklin J, Petsis D, Swyryn M, Lalley-Chareczko L, Koenig HC, Dowshen N. Wood S, et al. AIDS Behav. 2019 Oct;23(10):2719-2729. doi: 10.1007/s10461-019-02502-y. AIDS Behav. 2019. PMID: 30993479 Clinical Trial.
Short-term and sustained adherence were measured by urine tenofovir concentration and pharmacy refills, respectively. Optimal adherence was defined as having both urine tenofovir concentration consistent with dose ingestion within 48 h and pharmacy refills consisten …
Short-term and sustained adherence were measured by urine tenofovir concentration and pharmacy refills, respectively. Optimal adhe
324 results
Jump to page
Feedback